• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白介素-18 与川崎病患者冠状动脉病变。

Interleukin-18 and coronary artery lesions in patients with Kawasaki disease.

机构信息

Department of Pediatrics, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, ROC.

出版信息

J Chin Med Assoc. 2013 Aug;76(8):438-45. doi: 10.1016/j.jcma.2013.04.005. Epub 2013 Jun 13.

DOI:10.1016/j.jcma.2013.04.005
PMID:23769880
Abstract

BACKGROUND

Interleukin-18 (IL-18) plays an important role in mediating cytokine cascade leading to coronary artery lesions (CALs) in Kawasaki disease (KD). However, our research suggested that the literature regarding IL-18 and KD is limited. Consequently, this study aimed to evaluate the correlation between IL-18 and CALs in patients with KD.

METHODS

In this prospective study of 14 children with KD (seven without and seven with CALs in the acute phase), we obtained patient measurements of a series of serum IL-18 levels in the acute, subacute, and convalescent phases. Serum IL-18 levels were measured with a Bio-Plex cytokine assay. Control samples were obtained from 18 febrile children with viral infection.

RESULTS

Compared with febrile controls, patients with acute-stage CALs [postintravenous immunoglobulin (post-IVIG) period] had a significantly higher IL-18 level (88.4 ± 20.7 vs 56.0 ± 35.0 pg/mL, p = 0.006). However, those without acute-stage CALs (post-IVIG period) lacked similarly elevated IL-18 level readings (62.0 ± 40.6 vs 56.0 ± 35.0 pg/mL, p = 0.762). The IL-18 level of patients with acute-stage CALs did not decrease significantly until the convalescent phase (97.4 ± 55.8 vs 38.7 ± 22.6 pg/mL, p = 0.018), but for those without CALs, it decreased significantly in the subacute phase (60.2 ± 37.4 vs 23.6 ± 13.8 pg/mL, p = 0.018). In the subacute stage, there was a significant difference of IL-18 level between patients with and without acute-stage CALs (p = 0.048).

CONCLUSION

Our data show that IL-18 levels were elevated in the acute phase of KD and might be related to the formation of CALs.

摘要

背景

白细胞介素-18(IL-18)在介导细胞因子级联反应导致川崎病(KD)冠状动脉损伤(CALs)中发挥重要作用。然而,我们的研究表明,关于 IL-18 和 KD 的文献有限。因此,本研究旨在评估 IL-18 与 KD 患者 CALs 的相关性。

方法

在这项对 14 名川崎病患儿(急性期无 CALs7 例,有 CALs7 例)的前瞻性研究中,我们获得了患者在急性期、亚急性期和恢复期一系列血清 IL-18 水平的测量值。使用 Bio-Plex 细胞因子分析测定血清 IL-18 水平。对照样本取自 18 例病毒性感染发热儿童。

结果

与发热对照组相比,急性期伴有 CALs 的患儿[静脉注射免疫球蛋白(post-IVIG)后]的 IL-18 水平显著升高(88.4 ± 20.7 vs. 56.0 ± 35.0 pg/mL,p = 0.006)。然而,那些急性期无 CALs(post-IVIG 后)的患儿缺乏类似升高的 IL-18 水平(62.0 ± 40.6 vs. 56.0 ± 35.0 pg/mL,p = 0.762)。急性期伴有 CALs 的患儿的 IL-18 水平直到恢复期才明显下降(97.4 ± 55.8 vs. 38.7 ± 22.6 pg/mL,p = 0.018),但无 CALs 的患儿在亚急性期明显下降(60.2 ± 37.4 vs. 23.6 ± 13.8 pg/mL,p = 0.018)。在亚急性期,伴有和不伴有急性期 CALs 的患儿之间的 IL-18 水平存在显著差异(p = 0.048)。

结论

我们的数据表明,IL-18 水平在 KD 的急性期升高,可能与 CALs 的形成有关。

相似文献

1
Interleukin-18 and coronary artery lesions in patients with Kawasaki disease.白介素-18 与川崎病患者冠状动脉病变。
J Chin Med Assoc. 2013 Aug;76(8):438-45. doi: 10.1016/j.jcma.2013.04.005. Epub 2013 Jun 13.
2
Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.川崎病患者静脉注射免疫球蛋白抵抗及冠状动脉病变与Th1/Th2细胞因子谱的关系评估
Arthritis Rheum. 2013 Mar;65(3):805-14. doi: 10.1002/art.37815.
3
A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.一项前瞻性研究比较了川崎病患者血清 IL6 和 CRP 水平与冠状动脉变化和治疗反应的关系。
Rheumatol Int. 2019 Oct;39(10):1797-1801. doi: 10.1007/s00296-019-04375-9. Epub 2019 Jul 13.
4
Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.川崎病中静脉注射免疫球蛋白抵抗及冠状动脉病变的预测因素
Pediatr Rheumatol Online J. 2017 Mar 21;15(1):17. doi: 10.1186/s12969-017-0149-1.
5
Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.延迟静脉注射免疫球蛋白治疗增加了不同状态川崎病患儿冠状动脉病变的风险。
Postgrad Med. 2018 May;130(4):442-447. doi: 10.1080/00325481.2018.1468712. Epub 2018 May 10.
6
Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.川崎病冠状动脉病变相关危险因素的临床意义。
Kaohsiung J Med Sci. 2012 Jan;28(1):23-9. doi: 10.1016/j.kjms.2011.09.002. Epub 2011 Dec 11.
7
The elevated serum levels of calcineurin and nuclear factor of activated T-cells 1 in children with Kawasaki disease.川崎病患儿血清钙调神经磷酸酶和活化 T 细胞核因子 1 水平升高。
Pediatr Rheumatol Online J. 2020 Mar 17;18(1):23. doi: 10.1186/s12969-020-0420-8.
8
Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?英夫利昔单抗联合静脉注射免疫球蛋白(IVIG)与单独 IVIG 作为有冠状动脉损伤的川崎病患儿初始治疗的比较:双治疗更有效吗?
Pediatr Infect Dis J. 2018 Oct;37(10):976-980. doi: 10.1097/INF.0000000000001951.
9
Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease.血清 IL-41 可能是川崎病静脉注射免疫球蛋白抵抗和冠状动脉病变的生物标志物。
Int Immunopharmacol. 2023 Sep;122:110600. doi: 10.1016/j.intimp.2023.110600. Epub 2023 Jul 7.
10
The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.血清脂质在预测川崎病冠状动脉病变和静脉注射免疫球蛋白抵抗中的作用:一项队列研究。
J Int Med Res. 2024 May;52(5):3000605241252115. doi: 10.1177/03000605241252115.

引用本文的文献

1
Immunophenotype of Kawasaki Disease: Insights into Pathogenesis and Treatment Response.川崎病的免疫表型:对发病机制和治疗反应的见解
Life (Basel). 2025 Jun 25;15(7):1012. doi: 10.3390/life15071012.
2
Expression of Serum Ferritin, Human neutrophil lipocalin, Procalcitonin, and inflammatory factors in children with Kawasaki disease and their relationship to coronary artery lesions.血清铁蛋白、人中性粒细胞脂质运载蛋白、降钙素原及炎症因子在川崎病患儿中的表达及其与冠状动脉病变的关系
Am J Transl Res. 2025 Jan 15;17(1):286-293. doi: 10.62347/MIHQ2583. eCollection 2025.
3
Kawasaki Disease-Associated Cytokine Storm Syndrome.
川崎病相关细胞因子风暴综合征。
Adv Exp Med Biol. 2024;1448:365-383. doi: 10.1007/978-3-031-59815-9_25.
4
Characterization of Inflammatory Factors and T Cell Subpopulations in a Murine Model of Kawasaki Disease Induced by Candida albicans Cell Wall Extracts (CAWS).白色念珠菌细胞壁提取物(CAWS)诱导川崎病小鼠模型中炎症因子和 T 细胞亚群的特征。
Med Sci Monit. 2022 May 7;28:e936355. doi: 10.12659/MSM.936355.
5
Anti-inflammatory Treatment of Kawasaki Disease: Comparison of Current Guidelines and Perspectives.川崎病的抗炎治疗:现行指南与观点比较
Front Med (Lausanne). 2021 Nov 30;8:738850. doi: 10.3389/fmed.2021.738850. eCollection 2021.
6
The immune landscape of SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Children (MIS-C) from acute disease to recovery.儿童新冠病毒相关多系统炎症综合征(MIS-C)从急性期到恢复期的免疫图景。
iScience. 2021 Nov 19;24(11):103215. doi: 10.1016/j.isci.2021.103215. Epub 2021 Oct 2.
7
Prediction Model for Diagnosis of Kawasaki Disease Using iTRAQ-Based Analysis.基于iTRAQ分析的川崎病诊断预测模型
Children (Basel). 2021 Jul 5;8(7):576. doi: 10.3390/children8070576.
8
Identifying Circulating MicroRNA in Kawasaki Disease by Next-Generation Sequencing Approach.通过下一代测序技术鉴定川崎病中的循环 microRNA。
Curr Issues Mol Biol. 2021 Jun 25;43(2):485-500. doi: 10.3390/cimb43020037.
9
Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculitis-A Critical Review of Its Pathogenesis and Treatment.儿童多系统炎症综合征(MIS-C),一种病毒性心肌炎和系统性血管炎——对其发病机制及治疗的批判性综述
Front Pediatr. 2020 Dec 16;8:626182. doi: 10.3389/fped.2020.626182. eCollection 2020.
10
Associations between interleukin 18 gene polymorphisms and susceptibility to vasculitis: A meta-analysis.白细胞介素18基因多态性与血管炎易感性的关联:一项荟萃分析。
Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(2):203-211. doi: 10.36141/svdld.v37i2.9399. Epub 2020 Jun 30.